
Opinion|Videos|January 23, 2026
How Pneumococcal Vaccine Efficacy Is Measured and Affirmed
Author(s)Jeff Goad, PharmD, MPH, APH
Fact checked by: Ron Panarotti
Explore how pneumococcal vaccine efficacy is measured, its real-world impact, and the importance of immunobridging for informed vaccination decisions.
Advertisement
This segment breaks down how pneumococcal vaccine efficacy and effectiveness are measured and why these distinctions matter when interpreting clinical trial data and real-world outcomes. It also explores the role of immunobridging in the approval of newer pneumococcal conjugate vaccines, key clinical end points used to evaluate vaccine performance, and what serotype differences mean for patient protection. Together, these insights help pharmacists translate evidence into informed, patient-centered vaccination decisions.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC
4
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
5
































































































































